Please login to the form below

Not currently logged in
Email:
Password:

R&D centre proposed for Northern Ireland

The €4.7bn Global Pharmaceutical Centre of Excellence could create thousands of jobs in Northern Ireland

More than 4,500 jobs could be created in Co Kerry, Northern Ireland, under plans to create a €4.7bn Global Pharmaceutical Centre of Excellence (GPCE).

Over the next four years up to 50 small-to-medium-sized businesses will form part of the GPCE project, which plans a four-storey building with floor space of 27.5 acres.

Meanwhile, International Prevention Research Institute (IPRI), Global Research Services (GRS) and Optivia Biotechnology will create more than 300 jobs as part of the initiative.

The planned jobs are in R&D and are to come over the next 15 months. They will be based temporarily in an existing building in the town and recruitment will begin in May.

Professor Peter Boyle, head of the IPRI, a non-profit organisation advising several governments on public health, said the initiative by the GPCE was necessary for the development of medicine. "This could be a very important centre for the whole of Europe in five years," he said.

17th March 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

ema1
The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...

Infographics